Top 10 Companies Powering the Biotech Adhesives and Sealants Market (2026): Leaders Driving Innovation

In Business Insights
August 26, 2026


MARKET INTELLIGENCE OVERVIEW

Biotech Adhesives and Sealants Market Insights

Global Biotech Adhesives and Sealants market size was valued at USD 5.8 billion in 2025. The market is projected to grow from USD 6.1 billion in 2026 to USD 10.2 billion by 2034, exhibiting a CAGR of 6.5% during the forecast period. These adhesives and sealants are engineered biopolymers designed to bond, encapsulate, and protect biological components in pharmaceutical, diagnostic, and laboratory applications, offering biocompatibility, low toxicity, and controlled release properties.

📊
Current Market Size
5.8 USD Bn

2025 Value

📈
CAGR
6.5%

2026–2034

🎯
Forecast Market Size
10.2 USD Bn

By 2034

Strategic Market Outlook
Long-Term Industry Perspective
Biotech adhesives continue to gain traction as manufacturers seek sustainable, low‑toxicity bonding solutions for cell‑based therapies, diagnostic devices, and drug delivery systems. Regulatory scrutiny pushes higher quality standards, while expanding biotech hubs in Asia‑Pacific accelerate adoption.

🌐
Leading Region
North America

🌍
Emerging Region
Asia‑Pacific

In 2025, the global market for biotech adhesives and sealants reached USD 5.8 billion, reflecting a steady rise driven by the expanding use of biocompatible bonding solutions across pharmaceuticals, diagnostics, and laboratory equipment. These materials, often based on proteins, synthetic polymers, or hybrid bio‑polymers, provide reliable adhesion while maintaining low toxicity and supporting controlled release of therapeutic agents.

A biotech adhesive is a bio‑engineered bonding agent that forms a secure, often covalent, connection between biological tissues or medical device components. Unlike conventional adhesives, these products are designed to integrate seamlessly with living cells, exhibit predictable degradation profiles, and meet stringent regulatory safety criteria.

Top 10 Companies Powering the Market

1. Henkel AG & Co. KGaA

Headquarters: Düsseldorf, Germany
Key Offering: Advanced polymer‑based surgical sealants (e.g., BioGlue®)

Henkel’s portfolio blends high‑strength bonding with rapid set times, enabling surgeons to secure grafts and implants with minimal handling. The company’s focus on bio‑inspired chemistry allows it to deliver adhesives that match the mechanical properties of native tissue, reducing the risk of postoperative complications.

Sustainability Initiatives: Henkel invests in bio‑based polymer research, targeting carbon‑neutral production lines by 2035.

  • Robust R&D pipeline for next‑generation bio‑adhesives
  • Strategic acquisitions of niche technology firms
  • Long‑term contracts with major pharmaceutical and device manufacturers

2. 3M Company

Headquarters: St. Paul, Minnesota, USA
Key Offering: Acrylate‑based wound‑closure adhesives (e.g., Vetbond®)

3M’s adhesives are prized for their versatility across surgical and veterinary applications. By leveraging a global distribution network, the company ensures that its products reach both high‑end hospitals and community clinics, supporting a broad spectrum of patient needs.

Sustainability Initiatives: Focus on recyclable packaging and reduced solvent usage in manufacturing.

  • Continuous improvement of adhesive formulations for lower toxicity
  • Partnerships with environmental NGOs to promote responsible disposal
  • Investment in digital supply‑chain transparency

3. Dow Inc.

Headquarters: Midland, Michigan, USA
Key Offering: Biocompatible polymer adhesives for implantable devices

Dow’s chemistry expertise allows the company to craft adhesives that maintain stability in physiological environments, supporting the longevity of implantable medical devices. Its rigorous testing protocols provide confidence to clinicians and regulators alike.

Sustainability Initiatives: Investment in green chemistry to reduce hazardous by‑products.

  • Development of low‑toxicity adhesive formulations
  • Collaboration with academic research centers for advanced polymer synthesis
  • Commitment to ISO 14001 environmental standards

4. Sika AG

Headquarters: Winterthur, Switzerland
Key Offering: Form‑stable adhesives for orthopedic implants

Sika’s adhesives provide consistent performance across a range of implant materials, ensuring secure fixation while mitigating stress concentrations that could lead to implant failure.

Sustainability Initiatives: Circular economy projects to recycle adhesive waste streams.

  • Research into bio‑degradable adhesive variants
  • Partnerships with hospitals for real‑world performance data
  • Adherence to European environmental directives

5. H.B. Fuller Company

Headquarters: Northbrook, Illinois, USA
Key Offering: Specialty adhesives for cell‑therapy bioreactors

H.B. Fuller’s products enable precise bonding within cell‑therapy manufacturing lines, ensuring sterility and product integrity without compromising cell viability.

Sustainability Initiatives: Collaboration with research institutions to develop low‑toxicity, high‑performance adhesives.

  • Continuous innovation in bio‑compatible adhesive chemistry
  • Engagement with regulatory bodies for streamlined approval pathways
  • Focus on energy‑efficient manufacturing processes

6. Arkema S.A.

Headquarters: Paris, France
Key Offering: Bio‑based adhesive chemistries for medical devices

Arkema’s bio‑based adhesives reduce environmental impact while maintaining performance, appealing to manufacturers seeking greener alternatives.

Sustainability Initiatives: Zero‑waste manufacturing and carbon‑neutral production targets.

  • Development of renewable feedstock‑derived adhesives
  • Partnerships with EU sustainability initiatives
  • Investment in life‑cycle assessment tools

7. Ashland Global Holdings

Headquarters: Wilmington, Delaware, USA
Key Offering: Customized sealants for cell‑therapy bioreactors

Ashland’s tailored solutions address the unique sterility and mechanical requirements of cell‑therapy production lines, supporting the growing demand for personalized medicine.

Sustainability Initiatives: Regulatory compliance and environmental stewardship embedded in product development.

  • Focus on low‑toxicity, high‑performance formulations
  • Collaboration with industry consortia for standardization
  • Adoption of digital tools for process optimization

8. Dymax Corporation

Headquarters: Livermore, California, USA
Key Offering: Rapid‑cure photopolymers for point‑of‑care applications

Dymax’s photopolymers enable on‑site fabrication of custom medical devices, reducing turnaround times and improving patient outcomes.

Sustainability Initiatives: Energy‑efficient manufacturing and reduced waste streams.

  • Innovation in fast‑curing adhesive technologies
  • Integration of IoT for real‑time process monitoring
  • Commitment to ISO 9001 quality management

9. CryoLife

Headquarters: Plymouth, Massachusetts, USA
Key Offering: BioGlue® surgical adhesive

CryoLife’s BioGlue® provides robust bonding for vascular and soft‑tissue repairs, supporting surgeons in complex procedures.

Sustainability Initiatives: Clinical trials that emphasize patient safety and long‑term efficacy.

  • Extensive clinical validation studies
  • Partnerships with leading medical centers
  • Focus on product safety and regulatory compliance

10. TissueTech

Headquarters: Montreal, Canada
Key Offering: Adhesives for tissue‑engineering scaffold integration

TissueTech’s adhesives facilitate the assembly of complex tissue scaffolds, enabling the creation of functional tissue constructs for regenerative therapies.

Sustainability Initiatives: Collaborations with universities to develop next‑generation bio‑adhesives.

  • Research into scaffold‑adhesive synergy
  • Support for academic‑industry joint ventures
  • Adherence to ethical sourcing of raw materials

Future Trends Shaping the Market

1. Smart Adhesives with Responsive Features – Adhesives that alter their mechanical properties in response to temperature, pH, or mechanical load are emerging, enabling adaptive medical devices that can adjust to the body’s changing environment.

2. Bio‑Inspired Formulations – Researchers are mimicking natural adhesives such as mussel byssal threads and gecko setae to create adhesives that bond under wet conditions while remaining non‑sticky to skin.

3. Digital Integration – The convergence of adhesive technology with IoT and AI allows real‑time monitoring of bond integrity, predicting failure before it occurs and extending device lifespan.

4. Regenerative Medicine Expansion – As cell‑based therapies grow, the need for biocompatible sealants that can encapsulate living cells while delivering growth factors will drive innovation in formulation chemistry.

5. Environmental Sustainability – The push toward bio‑based, biodegradable adhesives will intensify, especially in regions with stringent environmental regulations and consumer demand for greener products.